Cambridge Major Laboratories
A CEO has been appointed to head AAIPharma Services and Cambridge Major Laboratories, two contract manufacturing organisations (CMOs) which merged last October.
Stephan Kutzer, will fill the position from August 1, 2014, taking over from Patrick Walsh, the former CEO of AAIPharma who has led the two companies since their merger.
Kutzer joins the companies from Lonza, where he was Chief Operating Officer (COO). He has also served as Chief Operating Officer or President of several of Lonza’s divisions, including Lonza Pharma Biotech, Lonza Custom Manufacturing, Lonza Biopharmaceuticals and Lonza Performance Chemicals. His background includes positions in operations, technical services, API (active pharmaceutical ingredient) development and manufacturing.